Portal de Periódicos da CAPES

The Metabolic Syndrome X

1999; Wiley; Volume: 892; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1999.tb07782.x

1749-6632

Barbara C. Hansen,

Regulation of Appetite and Obesity

Annals of the New York Academy of SciencesVolume 892, Issue 1 p. 1-24 The Metabolic Syndrome X BARBARA CALEEN HANSEN, Corresponding Author BARBARA CALEEN HANSEN Obesity and Diabetes Research Center, Department of Physiology, School of Medicine, University of Maryland, 10 South Pine Street #6-00, Baltimore, Maryland 21201, USA Tel: (410) 706-3168; fax: (703) 356-4143; e-mail: [email protected]Search for more papers by this author BARBARA CALEEN HANSEN, Corresponding Author BARBARA CALEEN HANSEN Obesity and Diabetes Research Center, Department of Physiology, School of Medicine, University of Maryland, 10 South Pine Street #6-00, Baltimore, Maryland 21201, USA Tel: (410) 706-3168; fax: (703) 356-4143; e-mail: [email protected]Search for more papers by this author First published: 06 February 2006 https://doi.org/10.1111/j.1749-6632.1999.tb07782.xCitations: 119Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Vague, J. 1947. La différenciation sexuelle, facteur déterminant des formes de l'obésité. Presse Méd. 55: 339–340. 2 Vague, J. 1953. La Différenciation Sexuelle Humaine. Masson. Paris. 3 Vague, J. 1956. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am. J. Clin. Nutr. 4: 20–34. 4 Vague, J., P. Vague & J. Jubelin. 1987. A 35-year follow up of diabetogenic obesity. Int. J. Obes. 11(Suppl. 2): 38. 5 Vague, J., P. Vague, J. Jubelin & A. Barre. 1987. Forms of obesity and metabolic disorders. Germ Verhandlungen der deutschen Gesellschaft fur Innere Medizin 93: 448–462. 6 Welborn, T. A., A. Breckenridge, A. H. Rubenstein, C. T. Dollery & T. R. Fraser. 1966. Serum insulin in essential hypertension and in peripheral vascular disease. Lancet 1: 1336–1337. 7 Welborn, T. A. & K. Wearne. 1979. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2: 154–160. 8 Camus, J. P. 1966. Goutte, diabéte, hyperlipémie: un trisyndrome métabolique. Rev. Rheumat. 33: 10–14. 9 Pyöryäyä K. 1979. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2: 131–141. 10 Modan, M., H. Halkin, S. Almog, A. Eshkol, M. Shefi, A. Shitrit & Z. Fuchs. 1985. Hyperinsulinemia. A link between hypertension, obesity, and glucose intolerance. J. Clin. Invest. 75: 809–817. 11 Modan, M., H. Halkin, A. Karasik & A. Lusky. 1987. Elevated serum uric acid-a facet of hyperinsulinaemia. Diabetologia 30: 713–718. 12 Lempiainen, P., L. Mykkanen, K. Pyorala, M. Laakso & J. Kuusisto. 1999. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 100(2): 123–128. 13 Liese, A. D., H. W. Hense, H. Lowel, A. Doring, M. Tietze & U. Keil. 1999. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization monitoring trends and determinants in cardiovascular diseases. Epidemiology 10(4): 391–397. 14 Hayashi, H., S. Nagasaka, S. Ishikawa, A. Kawakami, K. Rokkaku, T. Nakamura, T. Saito, I. Kusaka, M. Higashiyama, K. Kubota & T. Murakami. 1998. Contribution of a missense mutation (Trp64Arg) in beta3-adrenergic receptor gene to multiple risk factors in Japanese men with hyperuricemia [In Process Citation]. Endocr. J. 45(6): 779–784. 15 Reaven, G. 1988. Banting lecture 1988: Role of insulin resistance in human disease. Diabetologia 30: 1595–1607. 16 Foster, D. W. 1989. Insulin resistance-a secret killer? N. Engl. J. Med. 320: 733–734. 17 DeFronzo, R. & E. Ferrannini. 1991. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173–194. 18 Florez, H., E. Ryder, G. Campos, V. Fernandez, L. M. Morales, H. Valbuena, E. Rincon, M. E. Gomez & X. Raleigh. 1999. Women relatives of Hispanic patients with type 2 diabetes are more prone to exhibit metabolic disturbances. Invest. Clin. 40(2): 127–142. 19 Shafrir, E. 1996. Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. Diabetes Metab. 22(2): 122–131. 20 Chan, J. C. N., J. C. K. Cheung, E. M. C. Lau, J. Wooa, A. Y. W. Chan, R. Swaminathan & C. S. Cockrama. 1996. The metabolic syndrome in Hong Kong Chinese. The interrelationships among its components analyzed by structural equation modeling. Diabetes Care 19(9): 953–959. 21 Eriksson, J., S. Timela & V. Koivisto. 1997. Exercise and the metabolic syndrome. Diabetologia 40: 125–135. 22 Reaven, G. M. & A. Laws. 1999. Insulin resistance: The Metabolic Syndrome X. In Contemporary Endocrinology. Vol. 12. P. M. Conn, Ed.: 374. Humana Press. Totowa, NJ. 23 Cannon, R. A. 1998. The conundrum of cardiovascular syndrome X. Cardiol. Rev. 6: 213–229. 24 Fischer, A., D. E. Gutstein & V. Fuster. 1999. Thrombosis and coagulation abnormalities in the acute coronary syndromes. Cardiol. Clin. 17(2): 283–294. 25 Ferrara, L., E. Tagliamonte, G. Cice, M. Marracino & A. Iacono. 1998. [Syndrome X and microvascular angina]. Minerva Cardioangiol. 46(6): 181–193. 26 Nih-Nhlbi. 1998. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Government Printing Office, Washington, D.C. 27 Himsworth, H. P. 1936. Diabetes mellitus: its differentiation into insulin sensitive and insulin insensitive types. Lancet 1: 127–130. 28 Hansen, B. C., K.-L. Jen & J. Schwartz. 1988. Changes in insulin responses and binding in adipocytes from monkeys with obesity progressing to diabetes. Int. J. Obes. 12: 391–401. 29 Shafrir, E. & E. Ziv. 1998. Cellular mechanism of nutritionally induced insulin resistance: the desert rodent Psammomys obesus and other animals in which insulin resistance leads to detrimental outcome. J. Basic Clin. Physiol. Pharmacol. 9(2-4): 347–385. 30 Alberti, K. G. & P. Z. Zimmet. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15(7): 539–553. 31 Festa, A., R. D'agostino, Jr., L. Mykkanen, R. Tracy, B. V. Howard & S. M. Haffner. 1999. Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The insulin resistance atherosclerosis study. Arterioscler. Thromb. Vasc. Biol. 19(3): 605–610. 32 Panel, T. E. 1994. National Cholesterol Education Program Second Report. The expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 89: 1333–1445. 33 Wilson, P. W. F., R. B. D'agostino, D. Levy, A. M. Belanger, H. Silbershatz & W. B. Kannel. 1998. Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837–1847. 34 Hansen, B. C., H. K. Ortmeyer & N. L. Bodkin. 1995. Obesity, insulin-resistance and noninsulin-dependent diabetes in aging monkeys: implications for NIDDM in humans. In Lessons from Animal Diabetes. V. E. Shafrir & A. E. Renold, Eds.: 93-105. Smith-Gordon. UK. 35 Hansen, B. C. 1996. Animal models of the aging-associated metabolic syndrome of obesity. In Regulation of Body Weight: Biological and Behavioral Mechanisms. C. Bouchard & G. Bray, Eds.: 45-60. John Wiley & Sons. Chichester, UK. 36 Hansen, B. C. 1999. Primate animal models of type 2 diabetes. In Diabetes Mellitus: A Fundamental and Clinical Text. D. LeRoith, S. I. Taylor & J. M. Olesfky, Eds. Lippincott-Raven Publishers. Philadelphia, PA. 37 Diabetes Mellitus Expert Committee on the Diagnosis and Classification of Diabetes. 1997. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20: 1183–1187. 38 Rantala, A. O., H. Kauma, M. Lilja, M. J. Savolainen, A. Reunanen & Y. A. Kesa-Niemi. 1999. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J. Intern. Med. 245(2): 163–174. 39 Joint National Committee. 1993. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch. Intern. Med. 153: 154–183. 40 Wahi, S., C. D. Gatzka, B. Sherrard, H. Simpson, V. Collins, G. Dowse, P. Zimmet, G. Jennings & A. M. Dart. 1997. Risk factors for coronary heart disease in a population with a high prevalence of obesity and diabetes: a case-control study of the Polynesian population of Western Samoa. J. Cardiovasc. Risk 4(3): 173–178. 41 Ferrannini, E., G. Buzzigoli & R. Bonadonna. 1987. Insulin resistance in essential hypertension. N. Engl. J. Med. 317: 350–357. 42 Fulghesu, A. M., F. Cucinelli, V. Pavone, F. Murgia, M. Guido, A. Caruso, S. Mancuso & A. Lanzone. 1999. Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome. Hum. Reprod. 14(3): 611–617. 43 Mohamed-Ali, V., J. H. Pinkney, A. Panahloo, S. Cwyfan-Hughes, J. M. Holly & J. S. Yudkin. 1999. Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome. Clin. Endocrinol. (Oxf.) 50(2): 221–228. 44 Luyckx, F. H., A. J. Scheen, M. R. Letiexhe, C. Desaive, J. Gielen & P. J. Lefebvre. 1999. [How I treat … an individual with severe obesity and metabolic abnormalities with gastroplasty]. Rev. Med. Liege 54(3): 138–142. 45 Marceau, P., S. Biron, F. S. Hould, S. Marceau, S. Simard, S. N. Thung & J. G. Kral. 1999. Liver pathology and the metabolic syndrome X in severe obesity. J. Clin. Endocrinol. Metab. 84(5): 1513–1517. 46 Gottsater, A., M. Ahmed, P. Fernlund & G. Sundkvist. 1999. Autonomic neuropathy in Type 2 diabetic patients is associated with hyperinsulinaemia and hypertriglyceridaemia. Diabet. Med. 16(1): 49–54. 47 Hew, F. L., D. O'Neal, N. Kamarudin, F. P. Alford & J. D. Best. 1998. Growth hormone deficiency and cardiovascular risk. Baillieres Clin. Endocrinol. Metab. 12(2): 199–216. 48 Stoll, B. A. 1999. Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur. J. Clin. Nutr. 53(2): 83–87. 49 Tahtinen, T. M., M. J. Vanhala, J. A. Oikarinen & S. M. Keinanen-Kiukaanniemi. 1998. Effect of smoking on the prevalence of insulin resistance-associated cardiovascular risk factors among Finnish men in military service. J. Cardiovasc. Risk 5: 319–323. 50 Tuomi, T., A. Carlsson, H. Li, B. Isomaa, A. Miettinen, A. Nilsson, M. Nissen, B. O. Ehrnstrom, B. Forsen, B. Snickars, K. Lahti, C. Forsblom, C. Saloranta, M. R. Taskinen & L. C. Groop. 1999. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48(1): 150–157. 51 Dowse, G. K., P. Z. Zimmet & V. R. Collins. 1996. Insulin levels and the natural history of glucose intolerance in Nauruans. Diabetes 45(10): 1367–1372. 52 Hansen, B. C. & N. L. Bodkin. 1986. Heterogeneity of insulin responses: phases in the continuum leading to non-insulin-dependent diabetes mellitus. Diabetologia 29: 713–719. 53 Hansen, B. C. & N. L. Bodkin. 1990. β-cell hyperresponsiveness: earliest event in development of diabetes in monkeys. Am. J. Physiol. 259: R612–R617. 54 Bodkin, N. L., B. L. Metzger & B. C. Hansen. 1989. Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys. Am. J. Physiol. 256: E676–E681. 55 Yalow, R. S. & S. A. Berson. 1960. Immunoassay of endogenous plasma insulin in man. J. Clin. Invest. 39: 1157–1175. 56 Karam, J. H., G. M. Grodsky & P. H. Forsham. 1963. Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes 12: 197–204. 57 Bagdade, J. D., E. L. Bierman & J. D. Porte. 1967. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J. Clin. Invest. 46: 1549–1557. 58 Brunzell, J. D., R. P. Robertson, R. L. Lerner, W. R. Hazzard, J. W. Ensinck, E. L. Bierman & J. D. Porte. 1976. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J. Clin. Endocrinol. Metab. 42: 222–229. 59 Hansen, B. C. & N. L. Bodkin. 1985. Beta cell hyperresponsiveness to glucose precedes both fasting hyperinsulinemia and reduced glucose tolerance. (Abstr.) Diabetes 34 (Suppl. 1): 8A. 60 Defronzo, R. A. 1988. The triumvirate: β-cell, muscle, liver-A collusion responsible for NIDDM. Diabetes 37: 667–687. 61 Hansen, B. C. & H. K. Ortmeyer. 1999. Obesity, diabetes and aging: lessons from life-time studies in monkeys. In Progress in Obesity Research. B. Guy-Grand & G. Ailhaud, Eds. John Libbey, Inc. London. In press. 62 Finch, C. F., G. K. Dowse, V. R. Collins & P. Z. Zimmet. 1990. Quantifying the extent to which random plasma glucose underestimates diabetes prevalence in the Nauruan population. Diabetes Res. Clin. Pract. 10(2): 177–182. 63 Alberti, K. G. & P. Z. Zimmet. 1998. New diagnostic criteria and classification of diabetes-again? [editorial; comment]. Diabet. Med. 15(7): 535–536. 64 Ferrannini, E., S. M. Haffner, B. D. Mitchell & M. P. Stern. 1991. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34: 416–422. 65 Ortmeyer, H. K., N. L. Bodkin & B. C. Hansen. 1993. Insulin-mediated glycogen synthase activity in muscle of spontaneously insulin-resistant and diabetic rhesus monkeys. Am. J. Physiol. 265: R552–R558. 66 Considine, R. V., M. K. Sinha, M. L. Heiman, A. Kriauciunas, T. W. Stephens, M. R. Nyce, J. P. Ohannesian, C. C. Marco, L. J. McKee, T. L. Bauer & J. F. Caro. 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334(5): 292–295. 67 Bodkin, N. L., M. Nicolson, H. K. Ortmeyer & B. C. Hansen. 1996. Hyperleptinemia: relationship to adiposity and insulin resistance in the spontaneously obese rhesus monkey. Horm. Metab. Res. 28: 674–678. 68 De Silva, A., M. De Courten, P. Zimmet, G. Nicholson, M. Kotowicz, J. Pasco & G. R. Collier. 1998. Lifestyle factors fail to explain the variation in plasma leptin concentrations in women. Nutrition 14(9): 653–657. 69 Haffner, S. M., L. Mykkanen, D. L. Rainwater, P. Karhapaa & M. Laakso. 1999. Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men? Obes. Res. 7(2): 164–169. 70 Fruehwald-Schultes, B., A. Peters, W. Kern, J. Beyer & A. Pfutzner. 1999. Serum leptin is associated with serum uric acid concentrations in humans. Metabolism 48(6): 677–680. 71 Soderberg, S., T. Olsson, M. Eliasson, O. Johnson & B. Ahren. 1999. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J. Intern. Med. 245(5): 533–543. 72 Pi-Sunyer, F. X., B. Laferrere, L. J. Aronne & G. A. Bray. 1999. Therapeutic controversy: obesity-a modern-day epidemic. J. Clin. Endocrinol. Metab. 84(1): 3–12. 73 Hotta, K., N. L. Bodkin, Y. Arita, M. Muraguchi, H. K. Ortmeyer, T. Funahashi, B. C. Hansen & Y. Matsuzawa. 1998. Analysis of plasma adiponectin and leptin levels in rhesus monkeys. Int. J. Obes. 22: P249. 74 Saleh, J., N. Christou & K. Cianflone. 1999. Regional specificity of ASP binding in human adipose tissue. Am. J. Physiol. 276: E815–821. 75 Engeli, S., K. Gorzelniak, R. Kreutz, N. Runkel, A. Distler & A. M. Sharma. 1999. Co-expression of renin-angiotensin system genes in human adipose tissue [In Process Citation]. J. Hypertens. 17(4): 555–560. 76 Bjorntorp, P., G. Holm & R. Rosmond. 1999. Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabet. Med. 16(5): 373–383. 77 Pasquali, R., L. Gagliardi, V. Vincennati, A. Gambineri, D. Colitta, L. Ceroni & F. Casimirri. 1999. ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution and parameters of the metabolic syndrome. Int. J. Obes. Relat. Metab. Disord. 23(4): 419–424. 78 Tai, E. S., S. C. Emmanuel, S. K. Chew, B. Y. Tan & C. E. Tan. 1999. Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes 48(5): 1088–1092. 79 Valencia, M. E., P. H. Bennett, E. Ravussin, J. Esparza, C. Fox & L. O. Schulz. 1999. The Pima Indians in Sonora, Mexico. Nutr. Rev. 57: S55–57.discussion S57-58. 80 Strojek, K., W. Grzeszczak, E. Morawin, M. Adamski, B. Lacka & E. Ritz. 1998. Reduced insulin-mediated glucose uptake by euglycemic clamp in offspring of patients with type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 106(6): 470–474. 81 Chen, C. H., S. T. Tsai & P. Chou. 1999. Correlation of fasting serum C-peptide and insulin with markers of metabolic syndrome-X in a homogenous Chinese population with normal glucose tolerance. Int. J. Cardiol. 68(2): 179–186. 82 Pravenec, M., V. Zidek, M. Simakova, V. Kren, D. Krenova, K. Horky, M. Jachymova, B. Mikova, L. Kazdova, T. J. Aitman, P. C. Churchill, R. C. Webb, N. H. Hingarh, Y. Yang, J. M. Wang, E. M. Lezin & T. W. Kurtz. 1999. Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension. J. Clin. Invest. 103(12): 1651–1657. 83 Bodkin, N. L., H. K. Ortmeyer & B. C. Hansen. 1995. Long-term dietary restriction in older-aged rhesus monkeys: effects on insulin resistance. J. Gerontol.: Biol Sci. 50: B142–B147. 84 Bodkin, N. L. & B. C. Hansen. 1995. Prevention of Syndrome X by long-term dietary restriction (DR) in aged rhesus monkeys. Gerontologist 35 (Suppl. 1): 239. 85 Walder, K., C. R. Dascaliuc, P. A. Lewandowski, A. J. Sanigorski, P. Zimmet & G. R. Collier. 1997. The effect of dietary energy restriction on body weight gain and the development of noninsulin-dependent diabetes mellitus (NIDDM) in Psammomys obesus. Obes. Res. 5(3): 193–200. 86 Whaley, M. H., J. B. Kampert, H. W. Kohl III & S. N. Blair. 1999. Physical fitness and clustering of risk factors associated with the metabolic syndrome. Med. Sci. Sports Exercise 31(2): 287–293. 87 Berger, M. 1992. Risk of obesity in type II diabetes mellitus. Int. J. Obes. Relat. Metab. Disord. 16 (Suppl. 4): S29–33. 88 Hargreaves, M. 1998. Sir William Refshauge Lecture. Skeletal muscle glucose metabolism during exercise: implications for health and performance. J. Sci. Med. Sport 1(4): 195–202. 89 Sjostrom, C. D., L. Lissner & L. Sjostrom. 1998. Long-term effects of weight loss on hypertension and diabetes: the SOS intervention study. Int. J. Obes. 22(Suppl. 3): S78. 90 Pill, J. & H. F. Kuhnle. 1999. BM 17.0744: A structurally new antidiabetic compound with insulin-sensitizing and lipid-lowering activity. Metabolism 48(1): 34–40. 91 Nestler, J. E., D. J. Jakubowicz, P. Reamer, R. D. Gunn & G. Allan. 1999. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N. Engl. J. Med. 340(17): 1314–1320. 92 Scott, R., C. J. Lintott, P. Zimmet, L. Campbell, K. Bowen & T. Welborn. 1999. Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus? [In Process Citation]. Diabetes Res. Clin. Pract. 43(3): 179–185. 93 Marin, P. & S. Arver. 1998. Androgens and abdominal obesity. Baillieres Clin. Endocrinol. Metab. 12(3): 441–451. 94 Hansen, B. C. 1995. Obesity, diabetes, and insulin resistance: implications from molecular biology, epidemiology and experimental studies in humans and animals. Diabetes Care 18: A2–A9. 95 Shafrir, E. 1993. Animal models of syndrome X. Curr. Top. Diabetes Res. 12: 165–181. 96 Zimmet, P. 1991. The epidemiology of diabetes mellitus and related conditions. In The Diabetes Annual/6. K. Alberti & L. P. Krall, Eds. Elsevier. Amsterdam. 97 Kaplan, N. M. 1989. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Int. Med. 149: 1514–1520. 98 Crepaldi, G. & R. Nosadini. 1988. Diabetic cardiopathy: is it a real entity? [Review]. Diabet. Metab. Rev. 4: 273–288. 99 Zimmet, P. Z. 1992. Kelly West Lecture 1991. Challenges in diabetes epidemiology-from West to the rest. Diabetes Care 15: 232–252. 100 Hansen, B. C. 1999. Obesity and diabetes: The natural history. In Diabetes in the New Millennium. J. R. Turtle, T. Kaneko & S. Osato, Eds.: 151-160. Endocrinology and Diabetes Research Foundation, University of Sydney, Australia. Citing Literature Volume892, Issue1THE METABOLIC SYNDROME X: Convergence of Insulin Resistance, Glucose Intolerance, Hypertension, Obesity, and Dyslipidemias‐Searching for the Underlying DefectsNovember 1999Pages 1-24 ReferencesRelatedInformation